Limitation of nuclear division by protease inhibitors in cytochalasin-B-treated tumor cells.
D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects*; D002713:Chlorine / Q000494:pharmacology; D002875:Chromosomes / Q000187:drug effects; D003260:Contact Inhibition / Q000187:drug effects; D003571:Cytochalasin B / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004622:Embryo, Mammalian; D006801:Humans; D008239:Lysine / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental; D011480:Protease Inhibitors; D012208:Rhabdomyosarcoma; D014105:Tosyl Compounds / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology*
D011480:Protease Inhibitors; D014105:Tosyl Compounds; D014361:Trypsin Inhibitors; D003571:Cytochalasin B; D002713:Chlorine; D008239:Lysine